Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
How to address challenges of protocol interpretation and planning and eDiary design.
November 29, 2023
By: joe fahy
PPD clinical research business of Thermo Fisher Scientific
By: giota pelekanaki
The deployment and adoption of electronic patient-reported outcomes (ePRO) in clinical trials has increased significantly during, and since, the COVID-19 pandemic, given the many documented benefits of using electronic modalities to capture PRO data. As eDiaries have become more common, some well-established challenges still exist in their design and implementation. Continued raised awareness of key challenges by subject matter experts (SMEs) aims to encourage an industry change in the way sponsors plan and approach the inclusion of eDiaries. With that in mind, we have documented two early-stage challenges – protocol interpretation and planning and eDiary design – that need to be addressed. Challenge one: Protocol interpretation and planning One of the earliest and most important design challenges when implementing eDiaries is ascertaining exactly what data are required to be captured and when. Homegrown eDiaries rely upon the interpretation of trial protocols by vendors and SME teams from the sponsor or clinical research organizations (CROs). Protocols often do not include the level of detail necessary to begin eDiary build activities immediately. This is in stark contrast to validated questionnaires, the datapoints of which are mostly fixed, with little to no interpretation required. Experienced eCOA teams from vendors and CROs can work with varying levels of initial direction to produce an eDiary that meets the needs of the study. However, the amount of design to be delegated by the sponsor should be defined from the outset. Design versus development of an instrument should be considered during this phase and scientific resources should be added, if needed. Furthermore, scientific input ensures diary questions are written with a lay audience and, ideally, the specific participant population in mind. The development of an eDiary must therefore begin with consultation among the various stakeholders. While electronic clinical outcome assessment (eCOA) experts from CROs and technology vendors can catalyze discussions and decision-making, having the right sponsor stakeholders involved at an early stage is essential. This ideally includes representatives from medical and statistical departments, as well as data management and/or eCOA specialists. This early alignment of the study teams helps to avoid costly rework, late eDiary iterations and delays and/or compromises further down the line. Currently, sponsors can provide eCOA vendors with an incomplete list of variables to be collected, an initial draft of the diary workflow as a starting point or a diary used on another of their studies. When a diary designed for use on paper is used as a starting point, the migration to electronic administration must be given due consideration and explained to the sponsor team. This part of the process is well understood today and, most commonly, results in the revision of paper-specific words such as “tick” to words better suited for electronic use, such as “select” or “tap.” Most vendors start with an iterative design process taking the first primitive draft into an electronic format. The number of iterations from first to final version can be numerous and sponsors often underestimate the time input required from them at this crucial stage of design. Next, eCOA SMEs and vendors must find areas of the protocol that might be relevant for eCOA instruments, including:
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !